KARNALYTE RESOURCES INC (KRN.CA) Fundamental Analysis & Valuation

TSX:KRN • CA4856722083

Current stock price

0.35 CAD
0 (0%)
Last:

This KRN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. KRN.CA Profitability Analysis

1.1 Basic Checks

  • In the past year KRN has reported negative net income.
  • In the past year KRN has reported a negative cash flow from operations.
  • KRN had negative earnings in each of the past 5 years.
  • KRN had a negative operating cash flow in each of the past 5 years.
KRN.CA Yearly Net Income VS EBIT VS OCF VS FCFKRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • KRN has a Return On Assets (-16.19%) which is comparable to the rest of the industry.
  • The Return On Equity of KRN (-25.22%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROIC N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
KRN.CA Yearly ROA, ROE, ROICKRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for KRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRN.CA Yearly Profit, Operating, Gross MarginsKRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. KRN.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for KRN remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, KRN has more shares outstanding
  • There is no outstanding debt for KRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KRN.CA Yearly Shares OutstandingKRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
KRN.CA Yearly Total Debt VS Total AssetsKRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • KRN has an Altman-Z score of -27.07. This is a bad value and indicates that KRN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -27.07, KRN is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
  • KRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -27.07
ROIC/WACCN/A
WACCN/A
KRN.CA Yearly LT Debt VS Equity VS FCFKRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that KRN should not have too much problems paying its short term obligations.
  • KRN has a Current ratio (1.58) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.58 indicates that KRN should not have too much problems paying its short term obligations.
  • KRN has a better Quick ratio (1.58) than 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
KRN.CA Yearly Current Assets VS Current LiabilitesKRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. KRN.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.80% over the past year.
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. KRN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KRN.CA Price Earnings VS Forward Price EarningsKRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRN.CA Per share dataKRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KRN.CA Dividend Analysis

5.1 Amount

  • KRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KRN.CA Fundamentals: All Metrics, Ratios and Statistics

KARNALYTE RESOURCES INC

TSX:KRN (3/24/2026, 7:00:00 PM)

0.35

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07
Earnings (Next)03-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.65M
Revenue(TTM)N/A
Net Income(TTM)-1.02M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.62
P/tB 4.62
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.19%
ROE -25.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.94%
ROA(5y)-23.31%
ROE(3y)-27.54%
ROE(5y)-32.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6615.38%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z -27.07
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)6983.33%
Cap/Depr(5y)4698%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-81.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.26%
OCF growth 3YN/A
OCF growth 5YN/A

KARNALYTE RESOURCES INC / KRN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of KARNALYTE RESOURCES INC (KRN.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to KRN.CA.


What is the valuation status for KRN stock?

ChartMill assigns a valuation rating of 0 / 10 to KARNALYTE RESOURCES INC (KRN.CA). This can be considered as Overvalued.


What is the profitability of KRN stock?

KARNALYTE RESOURCES INC (KRN.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for KRN stock?

The financial health rating of KARNALYTE RESOURCES INC (KRN.CA) is 5 / 10.